["Substances capable of self-reproduction" as cellular targets of chemical carcinogens]

Volker Wunderlich1

  • 1Max Delbrück-Centrum für Molekulare Medizin, Berlin. vwunder@mdc-berlin.de

NTM
|March 20, 2008
PubMed

Insights

Carcinogens cause heritable changes by affecting self-reproducing cell substances. Early research hinted at DNA

Area of Science:

  • Chemical carcinogenesis
  • Molecular biology
  • Genetics

Background:

  • Hermann Druckrey and Karl Küpfmüller's 1948 studies on chemical carcinogenesis.
  • Animal experiments with carcinogenic azo dye and mathematical analysis.
  • Observation that carcinogens target self-reproducing cellular substances.

Discussion:

  • The chemical nature of these "substances" remained unidentified for many years.
  • Deoxyribonucleic acid (DNA) was later identified as a target for genotoxic carcinogens.
  • Retrospective analysis reveals Druckrey and Küpfmüller's work as an early, indirect indicator of DNA's role in cancer.

Key Insights:

  • Carcinogens induce heritable changes by targeting DNA, the sole self-reproducing molecule.
  • Druckrey and Küpfmüller's findings provide historical context for DNA's role in cancer development.
  • The study highlights the importance of understanding molecular targets in chemical carcinogenesis.

Outlook:

  • Re-evaluation of historical research in light of current scientific understanding.
  • Further investigation into the mechanisms of DNA damage and repair in carcinogenesis.
  • Potential for novel therapeutic strategies targeting DNA in cancer treatment.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).